Oppenheimer Lifts Salesforce (CRM) Price Target to $370 Ahead of Earnings

Salesforce, Inc. (NYSE:CRM) is one of the AI Stocks Investors Should Keep on Their Radar. On August 26, Oppenheimer analyst Brian Schwartz raised the price target on the stock to $370.00 (from $315.00) while maintaining an Outperform rating.

The rating update, issued ahead of the Q2 earnings print, comes with low expectations and multiples that signal multiple bad news. Oppenheimer’s research mosaic reflects softening business trends for the company and limited near-term catalysts.

The firm believes that the Q2 earnings print may not instigate new opinions on Salesforce. Moreover, it is highly unlikely that AI messaging and estimates change materially post results. Execution risks may also prevail in the 2H of 2026 due to macro and AI-related uncertainty.

Regardless, Agentforce and Data Cloud continue to be investable themes, while margin growth continues and multiples continue to discount many risks.

“Bottom line: In our view, the F2Q earnings update may not catalyze new opinions on CRM. AI messaging and estimates are unlikely to materially change post results and there remains execution risk in the 2H:FY26 from lingering macro- and AI-related uncertainty. Nevertheless, Agentforce and Data Cloud are investable themes, margin growth continues, and multiples are already discounting many risks. We lower our PT to $315 on group multiple compression.”

Salesforce, Inc. (NYSE:CRM) is a cloud-based CRM company that has gained popularity after it unveiled its AI-powered platform called Agentforce.

While we acknowledge the potential of CRM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 AI Stocks Hit with New Analyst Ratings and 10 Trending AI Stocks on Wall Street

Disclosure: None.